Tag: Pharmas
TME PHARMA – The US FDA grants Fast Track designation for NOX-A12, TME Pharma’s lead program, in brain cancer – 04/02/2024 at 8:30 p.m.
TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology company specializing in the development of novel therapies for the treatment of cancer by targeting the tumor microenvironment (TME), announces that…
Innate pharma: The half-billion revenue mark is approaching for Innate Pharma’s flagship molecule
(BFM Bourse) – The “monalizumab” molecule developed by French biotech and acquired by AstraZeneca aims to simultaneously boost the activity of two types of immune cells against cancer. The start…
Messenger RNA, Big Pharma’s new El Dorado
Laboratory assistants from BioNTech at the production site in Marburg (Germany), March 30, 2021. ROESSLER BORIS / DPA / ABACA Confined to research laboratories, far from hospitals and pharmacies, in…